Skip to Main Content

Author Details

Song Cao
Washington University in St Louis
2005
51
29
PMIDPaper TitleJournal TitlePublished Year
36779841Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.Cancer Res2023
37914932Epigenetic regulation during cancer transitions across 11 tumour types.Nature2023
36973268Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Nat Commun2023
36779841Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.Cancer Res2023
37198186Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Nat Commun2023
37914932Epigenetic regulation during cancer transitions across 11 tumour types.Nature2023
36973268Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Nat Commun2023
37198186Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Nat Commun2023
35169076LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint.Proc Natl Acad Sci U S A2022
35169076LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint.Proc Natl Acad Sci U S A2022
34996889Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.Nat Commun2022
34996889Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.Nat Commun2022
33963182Co-evolution of tumor and immune cells during progression of multiple myeloma.Nat Commun2021
33963182Co-evolution of tumor and immune cells during progression of multiple myeloma.Nat Commun2021
33577785Proteogenomic and metabolomic characterization of human glioblastoma.Cancer Cell2021
34429404Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.Nat Commun2021
33577785Proteogenomic and metabolomic characterization of human glioblastoma.Cancer Cell2021
34429404Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.Nat Commun2021
32471990Evolution and structure of clinically relevant gene fusions in multiple myeloma.Nat Commun2020
31923397Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.Cell2020
32471990Evolution and structure of clinically relevant gene fusions in multiple myeloma.Nat Commun2020
33149122Discovery of driver non-coding splice-site-creating mutations in cancer.Nat Commun2020
31923397Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.Cell2020
33149122Discovery of driver non-coding splice-site-creating mutations in cancer.Nat Commun2020
30911684Dynamic host immune response in virus-associated cancers.Commun Biol2019
31675502Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.Cell2019
30911684Dynamic host immune response in virus-associated cancers.Commun Biol2019
31196969Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.Mol Cell Proteomics2019
31675502Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.Cell2019
31196969Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.Mol Cell Proteomics2019
29625053Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
30096302Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29625052Pathogenic Germline Variants in 10,389 Adult Cancers.Cell2018
29625053Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29617666Systematic Analysis of Splice-Site-Creating Mutations in Cancer.Cell Rep2018
29617662Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.Cell Rep2018
30096302Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29617666Systematic Analysis of Splice-Site-Creating Mutations in Cancer.Cell Rep2018
29617662Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.Cell Rep2018
29625052Pathogenic Germline Variants in 10,389 Adult Cancers.Cell2018
28582538BreakPoint Surveyor: a pipeline for structural variant visualization.Bioinformatics2017
28348404Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.Nat Commun2017
28582538BreakPoint Surveyor: a pipeline for structural variant visualization.Bioinformatics2017
28440318Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.Nat Commun2017
28440318Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.Nat Commun2017
28348404Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.Nat Commun2017
27339696Divergent viral presentation among human tumors and adjacent normal tissues.Sci Rep2016
27251275Proteogenomics connects somatic mutations to signalling in breast cancer.Nature2016
27339696Divergent viral presentation among human tumors and adjacent normal tissues.Sci Rep2016
26657142Systematic discovery of complex insertions and deletions in human cancers.Nat Med2016
  • 1 - 50 of 102

Recommended Authors

Ivan A Belashov
University of Pittsburgh
Career Start Year 2012
Number of shared co-authors 0
Krishna Choudhary
Gladstone Institutes of Cardiovascular Disease, Gladstone Institutes
Career Start Year 2010
Number of shared co-authors 0
Michael T Zimmermann
Medical College of Wisconsin
Career Start Year 2009
Number of shared co-authors 7
Alvin Farrel
Children's Hospital of Philadelphia
Career Start Year 2008
Number of shared co-authors 1
Batsal Devkota
Children's Hospital of Philadelphia
Career Start Year 2008
Number of shared co-authors 1
Kristen K Dang
Benaroya Research Institute at Virginia Mason
Career Start Year 2006
Number of shared co-authors 8
Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
Career Start Year 2006
Number of shared co-authors 3
Julia F Hopkins
Foundation Medicine Inc.
Career Start Year 2005
Number of shared co-authors 2
Milana Frenkel-Morgenstern
Bar-Ilan University
Career Start Year 2005
Number of shared co-authors 0
Benjamin D Greenbaum
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Niko Beerenwinkel
ETH Zurich
Career Start Year 2002
Number of shared co-authors 3
Suleyman Cenk Sahinalp
National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 4
Lewyn Li
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 1
Jun-Tao Guo
University of North Carolina at Charlotte
Career Start Year 1999
Number of shared co-authors 0
Wei Wang
IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill
Career Start Year 1999
Number of shared co-authors 4
Marc A Marti-Renom
Universitat Pompeu Fabra (UPF)
Career Start Year 1998
Number of shared co-authors 1
Cameron Mura
University of Virginia
Career Start Year 1998
Number of shared co-authors 0
Vineet Bafna
University of California San Diego
Career Start Year 1998
Number of shared co-authors 16
Andres Ramos
Institute of Structural and Molecular Biology (ISMB), University College London
Career Start Year 1997
Number of shared co-authors 0
Takashi Nagata
Institute of Advanced Energy, Kyoto University
Career Start Year 1996
Number of shared co-authors 0
Debora S Marks
Blavatnik Institute, Harvard Medical School
Career Start Year 1995
Number of shared co-authors 6
Alexei A Podtelezhnikov
Genetics and Pharmacogenomics, Merck & Co., Inc.
Career Start Year 1994
Number of shared co-authors 1
Bonnie Berger
Massachusetts Institute of Technology
Career Start Year 1994
Number of shared co-authors 1
Patrick Gendron
University of Montreal
Career Start Year 1992
Number of shared co-authors 1
Zhiping Weng
University of Massachusetts Medical School
Career Start Year 1992
Number of shared co-authors 5
Mark Gerstein
Yale University
Career Start Year 1991
Number of shared co-authors 28
Anna Marie Pyle
Yale University, USA Howard Hughes Medical Institute
Career Start Year 1989
Number of shared co-authors 0
Jennifer A Doudna
Innovative Genomics Institute, University of California berkeley
Career Start Year 1987
Number of shared co-authors 0
Ruth Nussinov
Sackler School of Medicine, Tel Aviv University
Career Start Year 1980
Number of shared co-authors 4
Alain Laederach
University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 3

Collaborators

Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 23
Michael C Wendl
Washington University in St Louis
Co-authored papers 19
Matthew A Wyczalkowski
Washington University in St Louis
Co-authored papers 19
Feng Chen
Washington University in St Louis
Co-authored papers 16
Reyka G Jayasinghe
Washington University in St Louis
Co-authored papers 14
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers 10
Henry Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 10
Christopher R Kinsinger
Co-authored papers 10
Yize Li
Co-authored papers 9
Mehdi Mesri
Co-authored papers 9
John F DiPersio
Washington University School of Medicine
Co-authored papers 8
Kelly V Ruggles
Co-authored papers 8
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 7
Daniel Cui Zhou
Washington University in St. Louis
Co-authored papers 7
Qingsong Gao
Washington University in St. Louis
Co-authored papers 7
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Co-authored papers 7
Wen-Wei Liang
Washington University in St Louis
Co-authored papers 7
Sherri R Davies
Co-authored papers 7
Matthew J Ellis
Co-authored papers 7
Shunqiang Li
Co-authored papers 6
Emily Kawaler
Co-authored papers 6
Kuan-Lin Huang
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Matthew H Bailey
Department of Biology at Brigham Young University
Co-authored papers 5
Chia-Kuei Mo
Co-authored papers 5
Ravi Vij
Co-authored papers 5
Christopher J Yoon
Co-authored papers 5
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers 5
Steven M Foltz
Washington University in St. Louis
Co-authored papers 5
Nadezhda V Terekhanova
Co-authored papers 5
Kai Ye
Co-authored papers 5
Release 1.2